DEXILANT Delayed-release capsules Ref.[10006] Active ingredients: Dexlansoprazole

Source: FDA, National Drug Code (US)  Revision Year: 2020 

Product description

The active ingredient in DEXILANT (dexlansoprazole) delayed-release capsules, a proton pump inhibitor, is (+)2[(R)-{[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-yl] methyl} sulfinyl]-1H-benzimidazole, a compound that inhibits gastric acid secretion. Dexlansoprazole is the Renantiomer of lansoprazole (a racemic mixture of the R and S-enantiomers). Its empirical formula is: C16H14F3N3O2S, with a molecular weight of 369.36.

Dexlansoprazole has the following chemical structure:

Dexlansoprazole is a white to nearly white crystalline powder which melts with decomposition at 140°C. Dexlansoprazole is freely soluble in dimethylformamide, methanol, dichloromethane, ethanol, and ethyl acetate; and soluble in acetonitrile; slightly soluble in ether; and very slightly soluble in water; and practically insoluble in hexane.

Dexlansoprazole is stable when exposed to light. Dexlansoprazole is more stable in neutral and alkaline conditions than acidic conditions.

Dexlansoprazole is supplied for oral administration as a dual delayed-release formulation in capsules. The capsules contain dexlansoprazole in a mixture of two types of enteric-coated granules with different pH-dependent dissolution profiles [see Clinical Pharmacology (12.3)].

DEXILANT delayed-release capsules are available in two dosage strengths: 30 and 60 mg, per capsule. Each capsule contains enteric-coated granules consisting of dexlansoprazole (active ingredient) and the following inactive ingredients: sugar spheres, magnesium carbonate, sucrose, low-substituted hydroxypropyl cellulose, titanium dioxide, hydroxypropyl cellulose, hypromellose 2910, talc, methacrylic acid copolymers, polyethylene glycol 8000, triethyl citrate, polysorbate 80, and colloidal silicon dioxide. The components of the capsule shell include the following inactive ingredients: hypromellose, carrageenan and potassium chloride. Based on the capsule shell color, blue contains FD&C Blue No. 2 aluminum lake; gray contains black ferric oxide; and both contain titanium dioxide.

Dosage Forms and Strengths

DEXILANT delayed-release capsules.

  • 30 mg: strength is an opaque, blue and gray capsule imprinted with “TAP” and “30”.
  • 60 mg: strength is an opaque, blue capsule imprinted with “TAP” and “60”.
How Supplied

DEXILANT delayed-release capsules, 30 mg, are opaque, blue and gray with “TAP” and “30” imprinted on the capsule and supplied as:

NDC Number Size
64764-171-11 Unit dose package of 100
64764-171-30 Bottle of 30
64764-171-90 Bottle of 90
64764-171-19 Bottle of 1000

DEXILANT delayed-release capsules, 60 mg, are opaque, blue with “TAP” and “60” imprinted on the capsule and supplied as:

NDC NumberSize
64764-175-11 Unit dose package of 100
64764-175-30 Bottle of 30
64764-175-90 Bottle of 90
64764-175-19 Bottle of 1000

Drugs

Drug Countries
DEXILANT Brazil, Canada, Germany, Ecuador, Hong Kong, Israel, Lithuania, Poland, Singapore, United States

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.